AQKR - Hosszu,L.L.P.; Jackson,G.S.; Trevitt,C.R.; Jones,S.; Batchelor,M.; Bhelt,D.; Prodromidou,K.; Clarke,A.R.; Waltho,J.P.; Collinge,J. - The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPc - The Journal of Biological Chemistry 2004 Jul 2; 279(27): 28515-21
AOUD - Hosszu,L.L.P.; Jackson,G.S.; Trevitt,C.R.; Jones,S.; Batchelor,M.; Prodromidou,K.; Clarke,A.R.; Waltho,J.P.; Collinge,J. - The residue 129 polymorphism in human prion protein does not confer susceptibility to CJD by altering the structure or stability of PrPc - International Conference - Prion diseases: from basic research to intervention concepts - TSE-Forum, 08.10.-10.10.2003, Gasteig, München - Poster session - BR-76 and BR-110
AWPD - Trevitt,C.R.; Collinge,J. - A systematic review of prion therapeutics in experimental models of prion propagation - International Conference - Prion 2006: Strategies, advances and trends towards protection of society - 3.10.-6.10.2006, Torino, Italy, Lingotto Conference Centre - Poster sessions THE-19
AVLV - Trevitt,C.R.; Collinge,J. - A systematic review of prion therapeutics in experimental models - Brain: A Journal of Neurology 2006 Sep; 129(9): 2241-65
AONG - Trevitt,C.R.; Singh,P.N. - Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications. - American Journal of Clinical Nutrition 2003 Sep; 78(3 Suppl): 651S-656S